{"id":833096,"date":"2022-11-08T06:04:03","date_gmt":"2022-11-08T05:04:03","guid":{"rendered":"https:\/\/bebeez.it\/non-categorizzato\/sabra-reports-third-quarter-2022-results-provides-business-update\/"},"modified":"2022-11-08T06:04:03","modified_gmt":"2022-11-08T05:04:03","slug":"sabra-reports-third-quarter-2022-results-provides-business-update","status":"publish","type":"post","link":"https:\/\/bebeez.it\/en\/real-estate-in-asia-pacific\/sabra-reports-third-quarter-2022-results-provides-business-update\/","title":{"rendered":"Sabra Reports Third Quarter 2022 Results; Provides Business Update"},"content":{"rendered":"

IRVINE, Calif.–(BUSINESS WIRE)–#3Q22<\/a>–Sabra Health Care REIT, Inc. (\u201cSabra,\u201d the \u201cCompany\u201d or \u201cwe\u201d) (Nasdaq: SBRA) today announced its results of operations for the third quarter of 2022. In addition, the Company provided a business update.\n<\/p>\n

<\/a><\/p>\n

\nTHIRD QUARTER 2022 RESULTS AND RECENT EVENTS<\/span>\n<\/p>\n

Results per diluted common share for the third quarter of 2022 were as follows:<\/p>\n

Net Loss: $(0.22)<\/p>\n

FFO: $0.28<\/p>\n

Normalized FFO: $0.36<\/p>\n

AFFO: $0.34<\/p>\n

Normalized AFFO: $0.35<\/p>\n

EBITDARM Coverage Summary:<\/p>\n

Skilled Nursing\/Transitional Care:<\/p>\n

1.83x (pro forma for North American transition, Avamere lease amendment)<\/p>\n

1.60x (pro forma for North American transition, Avamere lease amendment, and excluding Provider Relief Funds)<\/p>\n

Senior Housing – Leased: 1.13x<\/p>\n

Behavioral Health: 1.72x<\/p>\n

Specialty Hospitals & Other: 7.30x<\/p>\n

As detailed in a separate press release, Sabra announced that it will transition the 24-property portfolio previously leased to North American Health Care, Inc. (\u201cNorth American\u201d) to two of Sabra\u2019s existing tenants, The Ensign Group (\u201cEnsign\u201d) and the Avamere Family of Companies (\u201cAvamere\u201d), for a combined initial annual rent of $34.5 million.<\/p>\n

During the third quarter of 2022, we acquired two senior housing managed communities, including one through our proprietary development pipeline, for $71.7 million with an estimated blended stabilized cash yield of 7.2%.<\/p>\n

During the third quarter of 2022, we generated $23.1 million of gross proceeds from the disposition of three facilities. As previously disclosed, we continue to make progress on additional dispositions that are expected to generate gross proceeds of over $200 million. The sales under contract are expected to close by December 31, 2022, subject to customary closing and diligence conditions.<\/p>\n

Our Net Debt to Adjusted EBITDA ratio was 5.50x as of September 30, 2022, and we expect to reduce leverage closer to our 5.0x long-term leverage target by the end of the year with proceeds from our disposition activity described above. We remain committed to maintaining a strong balance sheet and strengthening our portfolio without accessing the capital markets.<\/p>\n

On November 7, 2022, our Board of Directors declared a quarterly cash dividend of $0.30 per share of common stock. The dividend will be paid on November 30, 2022 to common stockholders of record as of the close of business on November 17, 2022.<\/p>\n

\nBUSINESS UPDATE<\/span>\n<\/p>\n

\nExpanding Relationship with Ensign and Avamere<\/span>\n<\/p>\n

\nAs detailed in a separate press release, Sabra announced that it will transition the 24-property portfolio previously leased to North American to two of Sabra\u2019s existing tenants, Ensign and Avamere, for a combined initial annual rent of $34.5 million. As a result, Ensign will become one of Sabra\u2019s largest relationships, representing approximately 8% of Annualized Cash NOI, while Avamere will remain one of Sabra\u2019s largest relationships, also accounting for roughly 8% of Annualized Cash NOI. Sabra believes this transaction represents a unique opportunity to improve the long-term value of this high-quality real estate portfolio, noting the enhanced credit profile that supports its rental income, highlighted by Ensign\u2019s corporate guaranty and $5 billion of equity market capitalization. The transition of these facilities to Ensign operating companies and Avamere is expected to be completed by February 1, 2023 and remains subject to the completion of certain regulatory approvals and other closing conditions. Sabra expects to recognize a total of $14.7 million in revenue from these facilities during the fourth quarter through the end of the transition period, which approximates the rent Sabra would have received during this timeframe under the previous leases with North American.\n<\/p>\n

\nCommenting on the third quarter\u2019s results, Rick Matros, CEO and Chair, said, \u201cThe transition of the North American portfolio should enhance the durability of Sabra\u2019s earnings stream going forward. We appreciate the extension of the Public Health Emergency as the health care industry continues to navigate the challenging operating environment. Although the recovery in both the skilled and senior housing asset classes has been slower than we all would have preferred, we are heartened by the continued, albeit slow, improvement in the labor market which has been a major barrier to a quicker recovery. The asset sales we previously disclosed are proceeding as expected and we continue to receive interest in acquiring additional skilled nursing assets. We plan on continuing this strategy which will further diversify our asset classes and fund our ongoing investment activity.\u201d\n<\/p>\n

\nLIQUIDITY\n<\/p>\n

\nAs of September 30, 2022, we had approximately $887.7 million of liquidity, consisting of unrestricted cash and cash equivalents of $26.3 million and available borrowings of $861.4 million under our revolving credit facility. As of September 30, 2022, we also had $475.0 million available under the ATM Program.\n<\/p>\n

\nCONFERENCE CALL AND COMPANY INFORMATION\n<\/p>\n

\nA conference call with a simultaneous webcast to discuss the 2022 third quarter results will be held on Tuesday, November 8, 2022 at 10:00 am Pacific Time. The webcast URL is https:\/\/edge.media-server.com\/mmc\/p\/eyzpt5x9<\/a>. To participate via telephone, please register in advance at https:\/\/register.vevent.com\/register\/BId527bdd7b5cd4bd685268d3255d6aed6<\/a> to receive a unique PIN needed to access the call. The dial-in number is (844) 543-0451. A digital replay of the call will be available on the Company\u2019s website at www.sabrahealth.com<\/a>. The Company\u2019s supplemental information package for the third quarter will also be available on the Company\u2019s website in the \u201cInvestors\u201d section.\n<\/p>\n

\nABOUT SABRA\n<\/p>\n

\nAs of September 30, 2022, Sabra\u2019s investment portfolio included 407 real estate properties held for investment (consisting of (i) 270 Skilled Nursing\/Transitional Care facilities, (ii) 52 Senior Housing communities (\u201cSenior Housing – Leased\u201d), (iii) 54 Senior Housing communities operated by third-party property managers pursuant to property management agreements (\u201cSenior Housing – Managed\u201d), (iv) 16 Behavioral Health facilities and (v) 15 Specialty Hospitals and Other facilities), one asset held for sale, one investment in a sales-type lease, 15 investments in loans receivable (consisting of two mortgage loans and 13 other loans), seven preferred equity investments and two investments in unconsolidated joint ventures. As of September 30, 2022, Sabra\u2019s real estate properties held for investment included 41,053 beds\/units, spread across the United States and Canada.\n<\/p>\n

\nFORWARD-LOOKING STATEMENTS SAFE HARBOR\n<\/p>\n

\nThis release contains \u201cforward-looking\u201d statements as defined in the Private Securities Litigation Reform Act of 1995. Any statements that do not relate to historical or current facts or matters are forward-looking statements. These statements may be identified, without limitation, by the use of \u201cexpects,\u201d \u201cbelieves,\u201d \u201cintends,\u201d \u201cshould\u201d or comparable terms or the negative thereof. Examples of forward-looking statements include all statements regarding our expectations regarding our recent and pending investments and dispositions; our pending transition of the North American portfolio and our expectations regarding the related impact on our earnings stream; our expectations regarding growth in our relationships with Ensign and Avamere and the resulting impact on the long-term value of the 24 properties to be transitioned to Ensign and Avamere; our expectations regarding our leverage ratio; and our other expectations regarding our future financial position, results of operations, cash flows, liquidity, business strategy, growth opportunities, potential investments and dispositions, and plans and objectives for future operations and capital raising activity.\n<\/p>\n

\nOur actual results may differ materially from those projected or contemplated by our forward-looking statements as a result of various factors, including, among others, the following: epidemic diseases, pandemics or other contagious diseases, including the ongoing impact of COVID-19, and measures intended to prevent their spread, and the related impact on our tenants, operators and Senior Housing – Managed communities; operational risks with respect to our Senior Housing – Managed communities; competitive conditions in our industry; the loss of key management personnel; uninsured or underinsured losses affecting our properties and the possibility of environmental compliance costs and liabilities; potential impairment charges and adjustments related to the accounting of our assets; the potential variability of our reported rental and related revenues as a result of Accounting Standards Update (\u201cASU\u201d) 2016-02, Leases, as amended by subsequent ASUs; risks associated with our investment in our unconsolidated joint ventures; catastrophic weather and other natural or man-made disasters, the effects of climate change on our properties and a failure to implement sustainable and energy-efficient measures; increased operating costs for our tenants and operators, due to labor market challenges and macroeconomic factors such as inflation; increased healthcare regulation and enforcement; our tenants\u2019 dependency on reimbursement from governmental and other third-party payor programs; the effect of our tenants declaring bankruptcy or becoming insolvent; our ability to find replacement tenants and the impact of unforeseen costs in acquiring new properties; the impact of litigation and rising insurance costs on the business of our tenants; the impact of required regulatory approvals of transfers of healthcare properties; environmental compliance costs and liabilities associated with real estate properties we own; our tenants\u2019 or operators\u2019 failure to adhere to applicable privacy and data security laws, or a material breach of our or our tenants\u2019 or operators\u2019 information technology; our concentration in the healthcare property sector, particularly in skilled nursing\/transitional care facilities and senior housing communities, which makes our profitability more vulnerable to a downturn in a specific sector than if we were investing in multiple industries; the significant amount of and our ability to service our indebtedness; covenants in our debt agreements that may restrict our ability to pay dividends, make investments, incur additional indebtedness and refinance indebtedness on favorable terms; increases in market interest rates; adverse changes in our credit ratings; our ability to make dividend distributions at expected levels; our ability to raise capital through equity and debt financings; changes in foreign currency exchange rates and other risks associated with our ownership of property outside the U.S.; the relatively illiquid nature of real estate investments; our ability to maintain our status as a real estate investment trust (\u201cREIT\u201d) under the federal tax laws; compliance with REIT requirements and certain tax and tax regulatory matters related to our status as a REIT; changes in tax laws and regulations affecting REITs; the ownership limits and takeover defenses in our governing documents and under Maryland law, which may restrict change of control or business combination opportunities; and the exclusive forum provisions in our bylaws.\n<\/p>\n

\nAdditional information concerning risks and uncertainties that could affect our business can be found in our filings with the Securities and Exchange Commission (the \u201cSEC\u201d), including in Part I, Item 1A of our Annual Report on Form 10-K for the year ended December 31, 2021. We do not intend, and we undertake no obligation, to update any forward-looking information to reflect events or circumstances after the date of this release or to reflect the occurrence of unanticipated events, unless required by law to do so.\n<\/p>\n

\nTENANT, OPERATOR AND BORROWER INFORMATION\n<\/p>\n

\nThis release includes information regarding certain of our tenants that lease properties from us and our operators and borrowers, most of which are not subject to SEC reporting requirements. The information related to our tenants, operators and borrowers that is provided in this release has been provided by, or derived from information provided by, such tenants, operators and borrowers. We have not independently verified this information. We have no reason to believe that such information is inaccurate in any material respect. We are providing this data for informational purposes only.\n<\/p>\n

\nNOTE REGARDING NON-GAAP FINANCIAL MEASURES\n<\/p>\n

\nThis release includes the following financial measures defined as non-GAAP financial measures by the SEC: Adjusted EBITDA, Net Debt to Adjusted EBITDA, net operating income (\u201cNOI\u201d), Cash NOI, Annualized Cash NOI, funds from operations (\u201cFFO\u201d), Normalized FFO, Adjusted FFO (\u201cAFFO\u201d), Normalized AFFO, FFO per diluted common share, Normalized FFO per diluted common share, AFFO per diluted common share and Normalized AFFO per diluted common share. These measures may be different than non-GAAP financial measures used by other companies, and the presentation of these measures is not intended to be considered in isolation or as a substitute for financial information prepared and presented in accordance with U.S. generally accepted accounting principles. An explanation of these non-GAAP financial measures is included under \u201cReporting Definitions\u201d in this release, and reconciliations of these non-GAAP financial measures to the GAAP financial measures we consider most comparable are included on the Investors section of our website at https:\/\/ir.sabrahealth.com\/investors\/financials\/quarterly-results<\/a>.\n<\/p>\n

\nSABRA HEALTH CARE REIT, INC.\n<\/p>\n

\nCONSOLIDATED STATEMENTS OF (LOSS) INCOME\n<\/p>\n

\n(dollars in thousands, except per share data)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\nThree Months Ended
\n
September 30,\n<\/p>\n

\n\u00a0\n<\/p>\n

\nNine Months Ended
\n
September 30,\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n2022\n<\/p>\n

\n\u00a0\n<\/p>\n

\n2021\n<\/p>\n

\n\u00a0\n<\/p>\n

\n2022\n<\/p>\n

\n\u00a0\n<\/p>\n

\n2021\n<\/p>\n

\nRevenues:\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\nRental and related revenues (1)<\/p>\n

\n$\n<\/p>\n

\n84,214\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n85,367\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n297,268\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n309,533\n<\/p>\n

\n\u00a0\n<\/p>\n

\nInterest and other income\n<\/p>\n

\n\u00a0\n<\/p>\n

\n8,940\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n3,405\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n28,585\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n9,377\n<\/p>\n

\n\u00a0\n<\/p>\n

\nResident fees and services\n<\/p>\n

\n\u00a0\n<\/p>\n

\n47,610\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n39,819\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n133,973\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n114,978\n<\/p>\n

\n\u00a0\n<\/p>\n

\nTotal revenues\n<\/p>\n

\n\u00a0\n<\/p>\n

\n140,764\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n128,591\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n459,826\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n433,888\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\nExpenses:\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\nDepreciation and amortization\n<\/p>\n

\n\u00a0\n<\/p>\n

\n47,427\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n45,046\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n137,855\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n133,912\n<\/p>\n

\n\u00a0\n<\/p>\n

\nInterest\n<\/p>\n

\n\u00a0\n<\/p>\n

\n27,071\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n24,243\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n77,573\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n72,956\n<\/p>\n

\n\u00a0\n<\/p>\n

\nTriple-net portfolio operating expenses\n<\/p>\n

\n\u00a0\n<\/p>\n

\n5,120\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n5,075\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n14,983\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n15,210\n<\/p>\n

\n\u00a0\n<\/p>\n

\nSenior housing – managed portfolio operating expenses\n<\/p>\n

\n\u00a0\n<\/p>\n

\n36,705\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n30,761\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n103,835\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n88,607\n<\/p>\n

\n\u00a0\n<\/p>\n

\nGeneral and administrative\n<\/p>\n

\n\u00a0\n<\/p>\n

\n9,676\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n8,683\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n28,721\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n26,432\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(Recovery of) provision for loan losses and other reserves\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(217\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(26\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(12\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n1,890\n<\/p>\n

\n\u00a0\n<\/p>\n

\nImpairment of real estate\n<\/p>\n

\n\u00a0\n<\/p>\n

\n60,857\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n495\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n72,602\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n495\n<\/p>\n

\n\u00a0\n<\/p>\n

\nTotal expenses\n<\/p>\n

\n\u00a0\n<\/p>\n

\n186,639\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n114,277\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n435,557\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n339,502\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\nOther income (expense):\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\nLoss on extinguishment of debt\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(140\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(913\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(411\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(1,760\n<\/p>\n

\n)\n<\/p>\n

\nOther income (expense)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n994\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n277\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(1,101\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n386\n<\/p>\n

\n\u00a0\n<\/p>\n

\nNet (loss) gain on sales of real estate\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(80\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n655\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(4,581\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(1,784\n<\/p>\n

\n)\n<\/p>\n

\nTotal other income (expense)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n774\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n19\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(6,093\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(3,158\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(Loss) income before loss from unconsolidated joint ventures and income tax expense\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(45,101\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n14,333\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n18,176\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n91,228\n<\/p>\n

\n\u00a0\n<\/p>\n

\nLoss from unconsolidated joint ventures\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(4,384\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(4,018\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(9,715\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(178,817\n<\/p>\n

\n)\n<\/p>\n

\nIncome tax expense\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(579\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(92\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(1,118\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(1,314\n<\/p>\n

\n)\n<\/p>\n

\nNet (loss) income\n<\/p>\n

\n$\n<\/p>\n

\n(50,064\n<\/p>\n

\n)\n<\/p>\n

\n$\n<\/p>\n

\n10,223\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n7,343\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n(88,903\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\nNet (loss) income, per:\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\nBasic common share\n<\/p>\n

\n$\n<\/p>\n

\n(0.22\n<\/p>\n

\n)\n<\/p>\n

\n$\n<\/p>\n

\n0.05\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n0.03\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n(0.41\n<\/p>\n

\n)\n<\/p>\n

\nDiluted common share\n<\/p>\n

\n$\n<\/p>\n

\n(0.22\n<\/p>\n

\n)\n<\/p>\n

\n$\n<\/p>\n

\n0.05\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n0.03\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n(0.41\n<\/p>\n

\n)\n<\/p>\n

\nWeighted-average number of common shares outstanding, basic\n<\/p>\n

\n\u00a0\n<\/p>\n

\n230,982,227\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n220,865,518\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n230,936,032\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n216,227,221\n<\/p>\n

\n\u00a0\n<\/p>\n

\nWeighted-average number of common shares outstanding, diluted\n<\/p>\n

\n\u00a0\n<\/p>\n

\n230,982,227\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n222,063,910\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n231,779,750\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n216,227,221\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(1)<\/p>\n

\nSee page 6 for additional details regarding Rental and related revenues.\n<\/p>\n

\u00a0<\/p>\n

\nSABRA HEALTH CARE REIT, INC.\n<\/p>\n

\nCONSOLIDATED STATEMENTS OF (LOSS) INCOME – SUPPLEMENTAL INFORMATION\n<\/p>\n

\n(in thousands)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\nThree Months Ended
\n
September 30,\n<\/p>\n

\n\u00a0\n<\/p>\n

\nNine Months Ended
\n
September 30,\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n2022\n<\/p>\n

\n\u00a0\n<\/p>\n

\n2021\n<\/p>\n

\n\u00a0\n<\/p>\n

\n2022\n<\/p>\n

\n\u00a0\n<\/p>\n

\n2021\n<\/p>\n

\nCash rental income\n<\/p>\n

\n$\n<\/p>\n

\n92,966\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n101,496\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n288,532\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n305,480\n<\/p>\n

\n\u00a0\n<\/p>\n

\nStraight-line rental income\n<\/p>\n

\n\u00a0\n<\/p>\n

\n2,006\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n3,391\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n7,042\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n11,114\n<\/p>\n

\n\u00a0\n<\/p>\n

\nStraight-line rental income receivable write-offs\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(16,606\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(25,213\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(17,068\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(25,213\n<\/p>\n

\n)\n<\/p>\n

\nAbove\/below market lease amortization\n<\/p>\n

\n\u00a0\n<\/p>\n

\n1,569\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n1,081\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n4,730\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n3,985\n<\/p>\n

\n\u00a0\n<\/p>\n

\nAbove\/below market lease intangible write-offs\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u2014\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u2014\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n326\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u2014\n<\/p>\n

\n\u00a0\n<\/p>\n

\nOperating expense recoveries\n<\/p>\n

\n\u00a0\n<\/p>\n

\n4,279\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n4,612\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n13,706\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n14,167\n<\/p>\n

\n\u00a0\n<\/p>\n

\nRental and related revenues\n<\/p>\n

\n$\n<\/p>\n

\n84,214\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n85,367\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n297,268\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n309,533\n<\/p>\n

\n\u00a0\n<\/p>\n

\u00a0<\/p>\n

\nSABRA HEALTH CARE REIT, INC.\n<\/p>\n

\nCONSOLIDATED BALANCE SHEETS\n<\/p>\n

\n(dollars in thousands, except per share data)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\nSeptember 30, 2022\n<\/p>\n

\n\u00a0\n<\/p>\n

\nDecember 31, 2021\n<\/p>\n

\nAssets\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\nReal estate investments, net of accumulated depreciation of $882,755 and $831,324 as of September 30, 2022 and December 31, 2021, respectively\n<\/p>\n

\n$\n<\/p>\n

\n5,018,903\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n5,162,884\n<\/p>\n

\n\u00a0\n<\/p>\n

\nLoans receivable and other investments, net\n<\/p>\n

\n\u00a0\n<\/p>\n

\n390,275\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n399,086\n<\/p>\n

\n\u00a0\n<\/p>\n

\nInvestment in unconsolidated joint ventures\n<\/p>\n

\n\u00a0\n<\/p>\n

\n207,616\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n96,680\n<\/p>\n

\n\u00a0\n<\/p>\n

\nCash and cash equivalents\n<\/p>\n

\n\u00a0\n<\/p>\n

\n26,289\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n111,996\n<\/p>\n

\n\u00a0\n<\/p>\n

\nRestricted cash\n<\/p>\n

\n\u00a0\n<\/p>\n

\n4,859\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n3,890\n<\/p>\n

\n\u00a0\n<\/p>\n

\nLease intangible assets, net\n<\/p>\n

\n\u00a0\n<\/p>\n

\n48,299\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n54,063\n<\/p>\n

\n\u00a0\n<\/p>\n

\nAccounts receivable, prepaid expenses and other assets, net\n<\/p>\n

\n\u00a0\n<\/p>\n

\n148,674\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n138,108\n<\/p>\n

\n\u00a0\n<\/p>\n

\nTotal assets\n<\/p>\n

\n$\n<\/p>\n

\n5,844,915\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n5,966,707\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\nLiabilities\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\nSecured debt, net\n<\/p>\n

\n$\n<\/p>\n

\n49,706\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n66,663\n<\/p>\n

\n\u00a0\n<\/p>\n

\nRevolving credit facility\n<\/p>\n

\n\u00a0\n<\/p>\n

\n138,551\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u2014\n<\/p>\n

\n\u00a0\n<\/p>\n

\nTerm loans, net\n<\/p>\n

\n\u00a0\n<\/p>\n

\n524,457\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n594,246\n<\/p>\n

\n\u00a0\n<\/p>\n

\nSenior unsecured notes, net\n<\/p>\n

\n\u00a0\n<\/p>\n

\n1,734,228\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n1,733,566\n<\/p>\n

\n\u00a0\n<\/p>\n

\nAccounts payable and accrued liabilities\n<\/p>\n

\n\u00a0\n<\/p>\n

\n145,217\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n142,989\n<\/p>\n

\n\u00a0\n<\/p>\n

\nLease intangible liabilities, net\n<\/p>\n

\n\u00a0\n<\/p>\n

\n44,023\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n49,713\n<\/p>\n

\n\u00a0\n<\/p>\n

\nTotal liabilities\n<\/p>\n

\n\u00a0\n<\/p>\n

\n2,636,182\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n2,587,177\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\nEquity\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\nPreferred stock, $0.01 par value; 10,000,000 shares authorized, zero shares issued and outstanding as of September 30, 2022 and December 31, 2021\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u2014\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u2014\n<\/p>\n

\n\u00a0\n<\/p>\n

\nCommon stock, $0.01 par value; 500,000,000 shares authorized, 230,976,606 and 230,398,655 shares issued and outstanding as of September 30, 2022 and December 31, 2021, respectively\n<\/p>\n

\n\u00a0\n<\/p>\n

\n2,310\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n2,304\n<\/p>\n

\n\u00a0\n<\/p>\n

\nAdditional paid-in capital\n<\/p>\n

\n\u00a0\n<\/p>\n

\n4,484,769\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n4,482,451\n<\/p>\n

\n\u00a0\n<\/p>\n

\nCumulative distributions in excess of net income\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(1,296,868\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(1,095,204\n<\/p>\n

\n)\n<\/p>\n

\nAccumulated other comprehensive income (loss)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n18,522\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(10,021\n<\/p>\n

\n)\n<\/p>\n

\nTotal equity\n<\/p>\n

\n\u00a0\n<\/p>\n

\n3,208,733\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n3,379,530\n<\/p>\n

\n\u00a0\n<\/p>\n

\nTotal liabilities and equity\n<\/p>\n

\n$\n<\/p>\n

\n5,844,915\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n5,966,707\n<\/p>\n

\n\u00a0\n<\/p>\n

\u00a0<\/p>\n

\nSABRA HEALTH CARE REIT, INC.\n<\/p>\n

\nCONSOLIDATED STATEMENTS OF CASH FLOWS\n<\/p>\n

\n(in thousands)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\nNine Months Ended September 30,\n<\/p>\n

\n\u00a0\n<\/p>\n

\n2022\n<\/p>\n

\n\u00a0\n<\/p>\n

\n2021\n<\/p>\n

\nCash flows from operating activities:\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\nNet income (loss)\n<\/p>\n

\n$\n<\/p>\n

\n7,343\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n(88,903\n<\/p>\n

\n)\n<\/p>\n

\nAdjustments to reconcile net income (loss) to net cash provided by operating activities:\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\nDepreciation and amortization\n<\/p>\n

\n\u00a0\n<\/p>\n

\n137,855\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n133,912\n<\/p>\n

\n\u00a0\n<\/p>\n

\nNon-cash rental and related revenues\n<\/p>\n

\n\u00a0\n<\/p>\n

\n4,970\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n10,113\n<\/p>\n

\n\u00a0\n<\/p>\n

\nNon-cash interest income\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(1,683\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(1,444\n<\/p>\n

\n)\n<\/p>\n

\nNon-cash interest expense\n<\/p>\n

\n\u00a0\n<\/p>\n

\n8,300\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n5,389\n<\/p>\n

\n\u00a0\n<\/p>\n

\nStock-based compensation expense\n<\/p>\n

\n\u00a0\n<\/p>\n

\n5,367\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n6,987\n<\/p>\n

\n\u00a0\n<\/p>\n

\nLoss on extinguishment of debt\n<\/p>\n

\n\u00a0\n<\/p>\n

\n411\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n1,760\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(Recovery of) provision for loan losses and other reserves\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(12\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n1,890\n<\/p>\n

\n\u00a0\n<\/p>\n

\nNet loss on sales of real estate\n<\/p>\n

\n\u00a0\n<\/p>\n

\n4,581\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n1,784\n<\/p>\n

\n\u00a0\n<\/p>\n

\nImpairment of real estate\n<\/p>\n

\n\u00a0\n<\/p>\n

\n72,602\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n495\n<\/p>\n

\n\u00a0\n<\/p>\n

\nOther-than-temporary impairment of unconsolidated joint venture\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u2014\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n164,126\n<\/p>\n

\n\u00a0\n<\/p>\n

\nLoss from unconsolidated joint ventures\n<\/p>\n

\n\u00a0\n<\/p>\n

\n9,715\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n14,691\n<\/p>\n

\n\u00a0\n<\/p>\n

\nOther non-cash items\n<\/p>\n

\n\u00a0\n<\/p>\n

\n2,167\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u2014\n<\/p>\n

\n\u00a0\n<\/p>\n

\nChanges in operating assets and liabilities:\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\nAccounts receivable, prepaid expenses and other assets, net\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(5,631\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n13,062\n<\/p>\n

\n\u00a0\n<\/p>\n

\nAccounts payable and accrued liabilities\n<\/p>\n

\n\u00a0\n<\/p>\n

\n2,161\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(5,403\n<\/p>\n

\n)\n<\/p>\n

\nNet cash provided by operating activities\n<\/p>\n

\n\u00a0\n<\/p>\n

\n248,146\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n258,459\n<\/p>\n

\n\u00a0\n<\/p>\n

\nCash flows from investing activities:\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\nAcquisition of real estate\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(83,985\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(62,116\n<\/p>\n

\n)\n<\/p>\n

\nOrigination and fundings of loans receivable\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(4,500\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u2014\n<\/p>\n

\n\u00a0\n<\/p>\n

\nOrigination and fundings of preferred equity investments\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(5,813\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(4,153\n<\/p>\n

\n)\n<\/p>\n

\nAdditions to real estate\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(33,809\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(29,278\n<\/p>\n

\n)\n<\/p>\n

\nEscrow deposits for potential investments\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(836\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u2014\n<\/p>\n

\n\u00a0\n<\/p>\n

\nRepayments of loans receivable\n<\/p>\n

\n\u00a0\n<\/p>\n

\n4,885\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n2,432\n<\/p>\n

\n\u00a0\n<\/p>\n

\nRepayments of preferred equity investments\n<\/p>\n

\n\u00a0\n<\/p>\n

\n4,173\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n683\n<\/p>\n

\n\u00a0\n<\/p>\n

\nInvestment in unconsolidated joint venture\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(128,019\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u2014\n<\/p>\n

\n\u00a0\n<\/p>\n

\nNet proceeds from the sales of real estate\n<\/p>\n

\n\u00a0\n<\/p>\n

\n62,816\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n15,066\n<\/p>\n

\n\u00a0\n<\/p>\n

\nNet cash used in investing activities\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(185,088\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(77,366\n<\/p>\n

\n)\n<\/p>\n

\nCash flows from financing activities:\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\nNet borrowings from revolving credit facility\n<\/p>\n

\n\u00a0\n<\/p>\n

\n147,353\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u2014\n<\/p>\n

\n\u00a0\n<\/p>\n

\nProceeds from issuance of senior unsecured notes\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u2014\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n791,520\n<\/p>\n

\n\u00a0\n<\/p>\n

\nPrincipal payments on term loans\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(63,750\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(455,000\n<\/p>\n

\n)\n<\/p>\n

\nPrincipal payments on secured debt\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(17,030\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(2,185\n<\/p>\n

\n)\n<\/p>\n

\nPayments of deferred financing costs\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(6\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(7,444\n<\/p>\n

\n)\n<\/p>\n

\nPayment of contingent consideration\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(2,500\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u2014\n<\/p>\n

\n\u00a0\n<\/p>\n

\nIssuance of common stock, net\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(4,394\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n172,188\n<\/p>\n

\n\u00a0\n<\/p>\n

\nDividends paid on common stock\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(207,861\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(194,311\n<\/p>\n

\n)\n<\/p>\n

\nNet cash (used in) provided by financing activities\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(148,188\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n304,768\n<\/p>\n

\n\u00a0\n<\/p>\n

\nNet (decrease) increase in cash, cash equivalents and restricted cash\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(85,130\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n485,861\n<\/p>\n

\n\u00a0\n<\/p>\n

\nEffect of foreign currency translation on cash, cash equivalents and restricted cash\n<\/p>\n

\n\u00a0\n<\/p>\n

\n392\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n34\n<\/p>\n

\n\u00a0\n<\/p>\n

\nCash, cash equivalents and restricted cash, beginning of period\n<\/p>\n

\n\u00a0\n<\/p>\n

\n115,886\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n65,523\n<\/p>\n

\n\u00a0\n<\/p>\n

\nCash, cash equivalents and restricted cash, end of period\n<\/p>\n

\n$\n<\/p>\n

\n31,148\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n551,418\n<\/p>\n

\n\u00a0\n<\/p>\n

\nSupplemental disclosure of cash flow information:\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\nInterest paid\n<\/p>\n

\n$\n<\/p>\n

\n68,778\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n66,051\n<\/p>\n

\n\u00a0\n<\/p>\n

\nSupplemental disclosure of non-cash investing activities:\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\nDecrease in loans receivable and other investments due to acquisition of real estate\n<\/p>\n

\n$\n<\/p>\n

\n14,311\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n\u2014\n<\/p>\n

\n\u00a0\n<\/p>\n

\u00a0<\/p>\n

\nSABRA HEALTH CARE REIT, INC.\n<\/p>\n

\nFUNDS FROM OPERATIONS (FFO), NORMALIZED FFO,\n<\/p>\n

\nADJUSTED FUNDS FROM OPERATIONS (AFFO) AND NORMALIZED AFFO\n<\/p>\n

\n(dollars in thousands, except per share data)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\nThree Months Ended
\n
September 30,\n<\/p>\n

\n\u00a0\n<\/p>\n

\nNine Months Ended
\n
September 30,\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n2022\n<\/p>\n

\n\u00a0\n<\/p>\n

\n2021\n<\/p>\n

\n\u00a0\n<\/p>\n

\n2022\n<\/p>\n

\n\u00a0\n<\/p>\n

\n2021\n<\/p>\n

\nNet (loss) income\n<\/p>\n

\n$\n<\/p>\n

\n(50,064\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n10,223\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n7,343\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n(88,903\n<\/p>\n

\n)\n<\/p>\n

\nAdd:\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\nDepreciation and amortization of real estate assets\n<\/p>\n

\n\u00a0\n<\/p>\n

\n47,427\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n45,046\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n137,855\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n133,912\n<\/p>\n

\n\u00a0\n<\/p>\n

\nDepreciation, amortization and impairment of real estate assets related to unconsolidated joint ventures\n<\/p>\n

\n\u00a0\n<\/p>\n

\n6,090\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n4,806\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n15,856\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n16,529\n<\/p>\n

\n\u00a0\n<\/p>\n

\nNet loss (gain) on sales of real estate\n<\/p>\n

\n\u00a0\n<\/p>\n

\n80\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(655\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n4,581\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n1,784\n<\/p>\n

\n\u00a0\n<\/p>\n

\nNet loss (gain) on sales of real estate related to unconsolidated joint ventures\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u2014\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n15\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(220\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n30\n<\/p>\n

\n\u00a0\n<\/p>\n

\nImpairment of real estate\n<\/p>\n

\n\u00a0\n<\/p>\n

\n60,857\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n495\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n72,602\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n495\n<\/p>\n

\n\u00a0\n<\/p>\n

\nOther-than-temporary impairment of unconsolidated joint ventures\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u2014\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u2014\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u2014\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n164,126\n<\/p>\n

\n\u00a0\n<\/p>\n

\nFFO\n<\/p>\n

\n$\n<\/p>\n

\n64,390\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n59,930\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n238,017\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n227,973\n<\/p>\n

\n\u00a0\n<\/p>\n

\nWrite-offs of cash and straight-line rental income receivable and lease intangibles\n<\/p>\n

\n\u00a0\n<\/p>\n

\n16,370\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n24,326\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n15,831\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n22,054\n<\/p>\n

\n\u00a0\n<\/p>\n

\nLease termination income\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u2014\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u2014\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(2,338\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u2014\n<\/p>\n

\n\u00a0\n<\/p>\n

\nLoss on extinguishment of debt\n<\/p>\n

\n\u00a0\n<\/p>\n

\n140\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n913\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n411\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n1,760\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(Recovery of) provision for credit and loan losses and other reserves\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(217\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(26\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(12\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n1,890\n<\/p>\n

\n\u00a0\n<\/p>\n

\nSupport payments paid to joint venture manager (1)<\/p>\n

\n\u00a0\n<\/p>\n

\n2,254\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u2014\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n5,880\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n2,450\n<\/p>\n

\n\u00a0\n<\/p>\n

\nOther normalizing items (2)<\/p>\n

\n\u00a0\n<\/p>\n

\n(65\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n148\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n2,586\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n852\n<\/p>\n

\n\u00a0\n<\/p>\n

\nNormalized FFO\n<\/p>\n

\n$\n<\/p>\n

\n82,872\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n85,291\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n260,375\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n256,979\n<\/p>\n

\n\u00a0\n<\/p>\n

\nFFO\n<\/p>\n

\n$\n<\/p>\n

\n64,390\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n59,930\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n238,017\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n227,973\n<\/p>\n

\n\u00a0\n<\/p>\n

\nStock-based compensation expense\n<\/p>\n

\n\u00a0\n<\/p>\n

\n2,117\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n2,428\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n5,367\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n6,987\n<\/p>\n

\n\u00a0\n<\/p>\n

\nNon-cash rental and related revenues\n<\/p>\n

\n\u00a0\n<\/p>\n

\n13,031\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n20,740\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n4,970\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n10,113\n<\/p>\n

\n\u00a0\n<\/p>\n

\nNon-cash interest income\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(589\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(530\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(1,683\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(1,444\n<\/p>\n

\n)\n<\/p>\n

\nNon-cash interest expense\n<\/p>\n

\n\u00a0\n<\/p>\n

\n2,798\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n1,744\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n8,300\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n5,389\n<\/p>\n

\n\u00a0\n<\/p>\n

\nNon-cash portion of loss on extinguishment of debt\n<\/p>\n

\n\u00a0\n<\/p>\n

\n140\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n913\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n411\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n1,760\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(Recovery of) provision for loan losses and other reserves\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(217\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(26\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(12\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n1,890\n<\/p>\n

\n\u00a0\n<\/p>\n

\nOther adjustments related to unconsolidated joint ventures\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(2,378\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(150\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(4,056\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(1,364\n<\/p>\n

\n)\n<\/p>\n

\nOther adjustments\n<\/p>\n

\n\u00a0\n<\/p>\n

\n36\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(213\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n2,430\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n320\n<\/p>\n

\n\u00a0\n<\/p>\n

\nAFFO\n<\/p>\n

\n$\n<\/p>\n

\n79,328\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n84,836\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n253,744\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n251,624\n<\/p>\n

\n\u00a0\n<\/p>\n

\nCash portion of lease termination income\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u2014\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u2014\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n(2,338\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u2014\n<\/p>\n

\n\u00a0\n<\/p>\n

\nWrite-off of cash rental income\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u2014\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u2014\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n71\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u2014\n<\/p>\n

\n\u00a0\n<\/p>\n

\nSupport payments paid to joint venture manager (1)<\/p>\n

\n\u00a0\n<\/p>\n

\n2,254\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u2014\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n5,880\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n2,450\n<\/p>\n

\n\u00a0\n<\/p>\n

\nOther normalizing items (2)<\/p>\n

\n\u00a0\n<\/p>\n

\n(80\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n405\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n250\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n963\n<\/p>\n

\n\u00a0\n<\/p>\n

\nNormalized AFFO\n<\/p>\n

\n$\n<\/p>\n

\n81,502\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n85,241\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n257,607\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n255,037\n<\/p>\n

\n\u00a0\n<\/p>\n

\nAmounts per diluted common share:\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\nNet income (loss)\n<\/p>\n

\n$\n<\/p>\n

\n(0.22\n<\/p>\n

\n)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n0.05\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n0.03\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n(0.41\n<\/p>\n

\n)\n<\/p>\n

\nFFO\n<\/p>\n

\n$\n<\/p>\n

\n0.28\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n0.27\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n1.03\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n1.05\n<\/p>\n

\n\u00a0\n<\/p>\n

\nNormalized FFO\n<\/p>\n

\n$\n<\/p>\n

\n0.36\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n0.38\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n1.12\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n1.18\n<\/p>\n

\n\u00a0\n<\/p>\n

\nAFFO\n<\/p>\n

\n$\n<\/p>\n

\n0.34\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n0.38\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n1.09\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n1.15\n<\/p>\n

\n\u00a0\n<\/p>\n

\nNormalized AFFO\n<\/p>\n

\n$\n<\/p>\n

\n0.35\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n0.38\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n1.11\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n$\n<\/p>\n

\n1.17\n<\/p>\n

\n\u00a0\n<\/p>\n

\nWeighted average number of common shares outstanding, diluted:\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\nNet income (loss)\n<\/p>\n

\n\u00a0\n<\/p>\n

\n230,982,227\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n222,063,910\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n231,779,750\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n216,227,221\n<\/p>\n

\n\u00a0\n<\/p>\n

\nFFO and Normalized FFO\n<\/p>\n

\n\u00a0\n<\/p>\n

\n231,993,295\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n222,063,910\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n231,779,750\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n217,385,804\n<\/p>\n

\n\u00a0\n<\/p>\n

\nAFFO and Normalized AFFO\n<\/p>\n

\n\u00a0\n<\/p>\n

\n232,858,600\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n222,542,049\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n232,810,528\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n\u00a0\n<\/p>\n

\n217,906,904\n<\/p>\n

\n\u00a0\n<\/p>\n

Contacts <\/p>\n

\nInvestor & Media Inquiries: (888) 393-8248 or investorinquiries@sabrahealth.com<\/a>\n<\/p>\n

Read full story here <\/a><\/p>","protected":false},"excerpt":{"rendered":"

IRVINE, Calif.–(BUSINESS WIRE)–#3Q22–Sabra Health Care REIT, Inc. (\u201cSabra,\u201d the \u201cCompany\u201d or \u201cwe\u201d) (Nasdaq: SBRA) today announced its results of operations for the third quarter of 2022. In addition, the Company provided a business update. THIRD QUARTER 2022 RESULTS AND RECENT EVENTS Results per diluted common share for the third quarter of 2022 were as follows: […]<\/p>\n","protected":false},"author":0,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[49630],"tags":[],"settori":[],"slider_categorie_and_home_page":[],"class_list":["post-833096","post","type-post","status-publish","format-standard","hentry","category-real-estate-in-asia-pacific"],"acf":[],"yoast_head":"\nSabra Reports Third Quarter 2022 Results; Provides Business Update - BeBeez<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/bebeez.it\/en\/real-estate-in-asia-pacific\/sabra-reports-third-quarter-2022-results-provides-business-update\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Sabra Reports Third Quarter 2022 Results; Provides Business Update - BeBeez\" \/>\n<meta property=\"og:description\" content=\"IRVINE, Calif.–(BUSINESS WIRE)–#3Q22–Sabra Health Care REIT, Inc. (\u201cSabra,\u201d the \u201cCompany\u201d or \u201cwe\u201d) (Nasdaq: SBRA) today announced its results of operations for the third quarter of 2022. In addition, the Company provided a business update. THIRD QUARTER 2022 RESULTS AND RECENT EVENTS Results per diluted common share for the third quarter of 2022 were as follows: […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/bebeez.it\/en\/real-estate-in-asia-pacific\/sabra-reports-third-quarter-2022-results-provides-business-update\/\" \/>\n<meta property=\"og:site_name\" content=\"BeBeez\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-08T05:04:03+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png\" \/>\n\t<meta property=\"og:image:width\" content=\"683\" \/>\n\t<meta property=\"og:image:height\" content=\"242\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data1\" content=\"14 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/bebeez.it\/en\/real-estate-in-asia-pacific\/sabra-reports-third-quarter-2022-results-provides-business-update\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/bebeez.it\/en\/real-estate-in-asia-pacific\/sabra-reports-third-quarter-2022-results-provides-business-update\/\"},\"author\":{\"name\":\"\",\"@id\":\"\"},\"headline\":\"Sabra Reports Third Quarter 2022 Results; Provides Business Update\",\"datePublished\":\"2022-11-08T05:04:03+00:00\",\"dateModified\":\"2022-11-08T05:04:03+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/bebeez.it\/en\/real-estate-in-asia-pacific\/sabra-reports-third-quarter-2022-results-provides-business-update\/\"},\"wordCount\":2859,\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"articleSection\":[\"Real Estate in Asia Pacific\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/bebeez.it\/en\/real-estate-in-asia-pacific\/sabra-reports-third-quarter-2022-results-provides-business-update\/\",\"url\":\"https:\/\/bebeez.it\/en\/real-estate-in-asia-pacific\/sabra-reports-third-quarter-2022-results-provides-business-update\/\",\"name\":\"Sabra Reports Third Quarter 2022 Results; Provides Business Update - BeBeez\",\"isPartOf\":{\"@id\":\"https:\/\/15.161.165.86\/#website\"},\"datePublished\":\"2022-11-08T05:04:03+00:00\",\"dateModified\":\"2022-11-08T05:04:03+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/bebeez.it\/en\/real-estate-in-asia-pacific\/sabra-reports-third-quarter-2022-results-provides-business-update\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/bebeez.it\/en\/real-estate-in-asia-pacific\/sabra-reports-third-quarter-2022-results-provides-business-update\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/bebeez.it\/en\/real-estate-in-asia-pacific\/sabra-reports-third-quarter-2022-results-provides-business-update\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/bebeez.it\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Sabra Reports Third Quarter 2022 Results; Provides Business Update\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/15.161.165.86\/#website\",\"url\":\"https:\/\/15.161.165.86\/\",\"name\":\"BeBeez\",\"description\":\"BeBeez\",\"publisher\":{\"@id\":\"https:\/\/15.161.165.86\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/15.161.165.86\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/15.161.165.86\/#organization\",\"name\":\"BeBeez\",\"url\":\"https:\/\/15.161.165.86\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"contentUrl\":\"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png\",\"width\":309,\"height\":122,\"caption\":\"BeBeez\"},\"image\":{\"@id\":\"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Sabra Reports Third Quarter 2022 Results; Provides Business Update - BeBeez","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/bebeez.it\/en\/real-estate-in-asia-pacific\/sabra-reports-third-quarter-2022-results-provides-business-update\/","og_locale":"en_US","og_type":"article","og_title":"Sabra Reports Third Quarter 2022 Results; Provides Business Update - BeBeez","og_description":"IRVINE, Calif.–(BUSINESS WIRE)–#3Q22–Sabra Health Care REIT, Inc. (\u201cSabra,\u201d the \u201cCompany\u201d or \u201cwe\u201d) (Nasdaq: SBRA) today announced its results of operations for the third quarter of 2022. In addition, the Company provided a business update. THIRD QUARTER 2022 RESULTS AND RECENT EVENTS Results per diluted common share for the third quarter of 2022 were as follows: […]","og_url":"https:\/\/bebeez.it\/en\/real-estate-in-asia-pacific\/sabra-reports-third-quarter-2022-results-provides-business-update\/","og_site_name":"BeBeez","article_published_time":"2022-11-08T05:04:03+00:00","og_image":[{"width":683,"height":242,"url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo-x2.png","type":"image\/png"}],"twitter_card":"summary_large_image","twitter_misc":{"Est. reading time":"14 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/bebeez.it\/en\/real-estate-in-asia-pacific\/sabra-reports-third-quarter-2022-results-provides-business-update\/#article","isPartOf":{"@id":"https:\/\/bebeez.it\/en\/real-estate-in-asia-pacific\/sabra-reports-third-quarter-2022-results-provides-business-update\/"},"author":{"name":"","@id":""},"headline":"Sabra Reports Third Quarter 2022 Results; Provides Business Update","datePublished":"2022-11-08T05:04:03+00:00","dateModified":"2022-11-08T05:04:03+00:00","mainEntityOfPage":{"@id":"https:\/\/bebeez.it\/en\/real-estate-in-asia-pacific\/sabra-reports-third-quarter-2022-results-provides-business-update\/"},"wordCount":2859,"publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"articleSection":["Real Estate in Asia Pacific"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/bebeez.it\/en\/real-estate-in-asia-pacific\/sabra-reports-third-quarter-2022-results-provides-business-update\/","url":"https:\/\/bebeez.it\/en\/real-estate-in-asia-pacific\/sabra-reports-third-quarter-2022-results-provides-business-update\/","name":"Sabra Reports Third Quarter 2022 Results; Provides Business Update - BeBeez","isPartOf":{"@id":"https:\/\/15.161.165.86\/#website"},"datePublished":"2022-11-08T05:04:03+00:00","dateModified":"2022-11-08T05:04:03+00:00","breadcrumb":{"@id":"https:\/\/bebeez.it\/en\/real-estate-in-asia-pacific\/sabra-reports-third-quarter-2022-results-provides-business-update\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/bebeez.it\/en\/real-estate-in-asia-pacific\/sabra-reports-third-quarter-2022-results-provides-business-update\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/bebeez.it\/en\/real-estate-in-asia-pacific\/sabra-reports-third-quarter-2022-results-provides-business-update\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/bebeez.it\/en\/"},{"@type":"ListItem","position":2,"name":"Sabra Reports Third Quarter 2022 Results; Provides Business Update"}]},{"@type":"WebSite","@id":"https:\/\/15.161.165.86\/#website","url":"https:\/\/15.161.165.86\/","name":"BeBeez","description":"BeBeez","publisher":{"@id":"https:\/\/15.161.165.86\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/15.161.165.86\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/15.161.165.86\/#organization","name":"BeBeez","url":"https:\/\/15.161.165.86\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/","url":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","contentUrl":"https:\/\/bebeez.it\/wp-content\/uploads\/2019\/10\/be-beez-logo.png","width":309,"height":122,"caption":"BeBeez"},"image":{"@id":"https:\/\/15.161.165.86\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/833096","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/types\/post"}],"replies":[{"embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/comments?post=833096"}],"version-history":[{"count":0,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/posts\/833096\/revisions"}],"wp:attachment":[{"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/media?parent=833096"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/categories?post=833096"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/tags?post=833096"},{"taxonomy":"settori","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/settori?post=833096"},{"taxonomy":"slider_categorie_and_home_page","embeddable":true,"href":"https:\/\/bebeez.it\/en\/wp-json\/wp\/v2\/slider_categorie_and_home_page?post=833096"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}